Lantronix Announces New X300 Compact Cellular IoT Gateway Solution, Ideal for Mission-Critical Applications
Globe Newswire28-03-2023, 18:00
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia 5-09-2023, 17:00